Our objective was to conduct a systematic review and meta-analysis for the use of modified (heat-killed or sonicated) probiotics for the efficacy and safety to prevent and treat various diseases. Recent clinical research has focused on living strains of probiotics, but use in high-risk patients and potential adverse reactions including bacteremia has focused interest on alternatives to the use of live probiotics. We searched MEDLINE/PubMed, Embase, Cochrane Central Register of Controlled Trials, CINAHL, Alt Health Watch, Web of Science, Scopus, PubMed, from inception to February 14, 2017 for randomised controlled trials involving modified probiotic strains. The primary outcome was efficacy to prevent or treat disease and the secondary outcome was incidence of adverse events. A total of 40 trials were included (n=3,913): 14 trials (15 arms with modified probiotics and 20 control arms) for the prevention of diseases and 26 trials (29 arms with modified probiotics and 32 control arms) for treatment of various diseases. Modified microbes were compared to either placebo (44%), or the same living probiotic strain (39%) or to only standard therapies (17%). Modified microbes were not significantly more or less effective than the living probiotic in 86% of the preventive trials and 69% of the treatment trials. Modified probiotic strains were significantly more effective in 15% of the treatment trials. Incidence rates of adverse events were similar for modified and living probiotics and other control groups, but many trials did not collect adequate safety data. Although several types of modified probiotics showed significant efficacy over living strains of probiotics, firm conclusions could not be reached due to the limited number of trials using the same type of modified microbe (strain, daily dose and duration) for a specific disease indication. Further research may illuminate other strains of modified probiotics that may have potential as clinical biotherapeutics.
Purchase
Buy instant access (PDF download and unlimited online access):
Institutional Login
Log in with Open Athens, Shibboleth, or your institutional credentials
Personal login
Log in with your brill.com account
Addams, C., 2010. The probiotic paradox: live and dead cells are biological response modifiers. Nutrition Research Reviews 23: 37-46.
'The probiotic paradox: live and dead cells are biological response modifiers ' () 23 Nutrition Research Reviews : 37 -46.
Al Faleh, K. and Anabrees, J., 2014. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Evidence Based Child Health 9: 584-671.
'Probiotics for prevention of necrotizing enterocolitis in preterm infants ' () 9 Evidence Based Child Health : 584 -671.
Alberda, C., Gramlich, L., Meddings, J., Field, C., McCargar, L., Kutsogiannis, D., Fedorak, R. and Madsen, K., 2007. Effects of probiotic therapy in critically ill patients: a randomized, double-blind, placebo-controlled trial. American Journal of Clinical Nutrition 85: 816-823.
'Effects of probiotic therapy in critically ill patients: a randomized, double-blind, placebo-controlled trial ' () 85 American Journal of Clinical Nutrition : 816 -823.
Arkwright, P.D. and David, T.J., 2003. Effect of Mycobacterium vaccae on atopic dermatitis in children of different ages. British Journal of Dermatology 149: 1029-1034.
'Effect of Mycobacterium vaccae on atopic dermatitis in children of different ages ' () 149 British Journal of Dermatology : 1029 -1034.
Awad, H., Mokhtar, H., Imam, S.S., Gad, G.I., Hafez, H. and Aboushady, N., 2010. Comparison between killed and living probiotic usage versus placebo for the prevention of necrotizing enterocolitis and sepsis in neonates. Pakistan Journal of Biological Sciences 13: 253-262.
'Comparison between killed and living probiotic usage versus placebo for the prevention of necrotizing enterocolitis and sepsis in neonates ' () 13 Pakistan Journal of Biological Sciences : 253 -262.
Bayona-González, A., López-Cámara, V. and Gómez-Castellanos, A., 1990. Final results of a dental caries clinical trial using heat killed lactic bacteria (streptococci and lactobacilli) orally. Practica Odontologica 11: 41-47.
'Final results of a dental caries clinical trial using heat killed lactic bacteria (streptococci and lactobacilli) orally ' () 11 Practica Odontologica : 41 -47.
Begg, C.B. and Mazumdar, M., 1994. Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088-1101.
'Operating characteristics of a rank correlation test for publication bias ' () 50 Biometrics : 1088 -1101.
Boulloche, J., Mouterde, O. and Mallet, E., 1994. Management of acute diarrhoea in infants and young children. Controlled study of the anti-diarrheal efficacy of killed L. acidophilus (LB strain) versus a placebo and a reference drug (loperamide). Annales de Pédiatrie 41: 457-463.
'Management of acute diarrhoea in infants and young children ' () 41 Annales de Pédiatrie : 457 -463.
Briand, V., Buffet, P., Genty, S., Lacombe, K., Godineau, N., Salomon, J., Vandemelbrouck, E., Ralaimazava, P., Goujon, C., Matheron, S., Fontanet, A. and Bouchaud, O., 2006. Absence of efficacy of nonviable Lactobacillus acidophilus for the prevention of travelerâs diarrhea: a randomized, double-blind, controlled study. Clinical Infectious Disease 43: 1170-1175.
'Absence of efficacy of nonviable Lactobacillus acidophilus for the prevention of travelerâs diarrhea: a randomized, double-blind, controlled study ' () 43 Clinical Infectious Disease : 1170 -1175.
Brothers, S., Asher, M.I., Jaksic, M. and Stewart, A.W., 2009. Effect of a Mycobacterium vaccae derivative on paediatric atopic dermatitis: a randomized, controlled trial. Clinical and Experimental Dermatology 34: 770-775.
'Effect of a Mycobacterium vaccae derivative on paediatric atopic dermatitis: a randomized, controlled trial ' () 34 Clinical and Experimental Dermatology : 770 -775.
Canducci, F., Armuzzi, A., Cremonini, F., Cammarota, G., Bartolozzi, F., Pola, P., Gasbarrini, G. and Gasbarrini, A., 2000. A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates. Alimentary Pharmacology and Therapeutics 14: 1625-1629.
'A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates ' () 14 Alimentary Pharmacology and Therapeutics : 1625 -1629.
Christensen, E., 2007. Methodology of superiority vs equivalence trials and non-inferiority trials. Journal of Hepatology 46: 947-954.
'Methodology of superiority vs equivalence trials and non-inferiority trials ' () 46 Journal of Hepatology : 947 -954.
Cruchet, S., Furnes, R., Maruy, A., Hebel, E., Palacios, J., Medina, F., Ramirez, N., Orsi, M., Rondon, L., Sdepanian, V., Xóchihua, L., Ybarra, M. and Zablah, R.A., 2015. The use of probiotics in pediatric gastroenterology: a review of the literature and recommendations by Latin-American experts. Paediatric Drugs 17: 199-216.
'The use of probiotics in pediatric gastroenterology: a review of the literature and recommendations by Latin-American experts ' () 17 Paediatric Drugs : 199 -216.
Cruchet, S., Obregon, M.C., Salazar, G., Diaz, E. and Gotteland, M., 2003. Effect of the ingestion of a dietary product containing Lactobacillus johnsonii La1 on Helicobacter pylori colonization in children. Nutrition 19: 716-721. Deshpande, G., Rao, S. and Patole, S., 2011. Progress in the field of probiotics: year 2011. Current Opinion in Gastroenterology 27: 13-18.
'Effect of the ingestion of a dietary product containing Lactobacillus johnsonii La1 on Helicobacter pylori colonization in children ' () 27 Current Opinion in Gastroenterology : 13 -18.
Doern, C.D., Nguyen, S.T., Afolabi, F., Burnham, C.A., 2014. Probiotic-associated aspiration pneumonia due to Lactobacillus rhamnosus. Journal of Clinical Microbiology 52: 3124-3126.
'Probiotic-associated aspiration pneumonia due to Lactobacillus rhamnosus ' () 52 Journal of Clinical Microbiology : 3124 -3126.
Doron, S. and Snydman, D.R., 2015. Risk and safety of probiotics. Clinical Infectious Diseases 60, Suppl. 2: S129-S134.
'Risk and safety of probiotics ' () 2 Clinical Infectious Diseases : S129 -S134.
Egger, M., Davey Smith, G., Schneider, M. and Minder, C., 1997. Bias in meta-analysis detected by a simple, graphical test. British Medical Journal 315: 629-634.
'Bias in meta-analysis detected by a simple, graphical test ' () 315 British Medical Journal : 629 -634.
Food and Agriculture Organisation/World Health Organization (FAO/WHO), 2002. Guidelines for the evaluation of probiotics in food. Report of a joint FAO/WHO working group on drafting guidelines for the evaluation of probiotics in food. Available at: ftp://ftp.fao.org/es/esn/food/wgreport2.pdf.
Ford, A.C., Quigley, E.M., Lacy, B.E., Lembo, A.J., Saito, Y.A., Schiller, L.R., Soffer, E.E., Spiegel, B.M. and Moayyedi, P., 2014. Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis. American Journal of Gastroenterology 109: 1547-1561.
'Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis ' () 109 American Journal of Gastroenterology : 1547 -1561.
Goldenberg, J.Z., Lytvyn, L., Steurich, J., Parkin, P., Mahant, S. and Johnston, B.C., 2015. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database of Systematic Reviews Issue 12: CD004827.
'Probiotics for the prevention of pediatric antibiotic-associated diarrhea ' () 12 Cochrane Database of Systematic Reviews Issue : CD004827.
Gotoh, M., Sahihara, T., Ikegami, S., Yamaji, T., Kino, K., Orii, N., Taketomo, N. and Okubo, K., 2009. Efficacy of oral administration of heat-killed Lactobacillus gasseri OLL2809 on patients of Japanese cedar pollinosis with high Japanese cedar pollinosis specific-IgE. Bioscience Biotechnology and Biochemistry 73: 1971-1977.
'Efficacy of oral administration of heat-killed Lactobacillus gasseri OLL2809 on patients of Japanese cedar pollinosis with high Japanese cedar pollinosis specific-IgE ' () 73 Bioscience Biotechnology and Biochemistry : 1971 -1977.
Gotteland, M., Andrews, M., Toledo, M., Muñoz, L., Caceres, P., Anziani, A., Wittig, E., Speisky, H. and Salazar, G., 2008. Modulation of Helicobacter pylori colonization with cranberry juice and Lactobacillus johnsonii La1 in children. Nutrition 24: 421-426.
'Modulation of Helicobacter pylori colonization with cranberry juice and Lactobacillus johnsonii La1 in children ' () 24 Nutrition : 421 -426.
Gotteland, M., Poliak, L., Cruchet, S. and Brunser, O., 2005. Effect of regular ingestion of Saccharomyces boulardii plus inulin or Lactobacillus acidophilus LB in children colonized by Helicobacter pylori. Acta Pædiatrica 94: 1747-1751.
'Effect of regular ingestion of Saccharomyces boulardii plus inulin or Lactobacillus acidophilus LB in children colonized by Helicobacter pylori ' () 94 Acta Pædiatrica : 1747 -1751.
Grand View Research, 2016. Nutraceuticals and functional foods. Global Industry Report. Available at: http://tinyurl.com/h2auhn8.
Guarner, F., Khan, A.G., Garisch, J., Eliakim, R., Gangl, A., Thomson, A., Krabshuis, J., Lemair, T., Kaufmann, P., De Paula, J.A., Fedorak, R., Shanahan, F., Sanders, M.E., Szajewska, H., Ramakrishna, B.S., Karakan, T. and Kim, N., 2012. World Gastroenterology Organisation global guidelines: probiotics and prebiotics October 2011. Journal of Clinical Gastroenterology 46: 468-481.
'World Gastroenterology Organisation global guidelines: probiotics and prebiotics October 2011 ' () 46 Journal of Clinical Gastroenterology : 468 -481.
Guyonnet, D., Chassany, O., Ducrotte, P., Picard, C., Mouret, M., Mercier, C.H. and Matuchansky, C., 2007. Effect of a fermented milk containing Bifidobacterium animalis DN-173010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled trial. Alimentary Pharmacology and Therapeutics 26: 475-448.
'Effect of a fermented milk containing Bifidobacterium animalis DN-173010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled trial ' () 26 Alimentary Pharmacology and Therapeutics : 475 -448.
Halpern, G.M., Prindiville, T., Blankenburg, M., Hsia, T. and Gershwin, M.E., 1996. Treatment of irritable bowel syndrome with Lacteol Fort: a randomized, double-blind, cross-over trial. American Journal of Gastroenterology 91: 1579-1585.
'Treatment of irritable bowel syndrome with Lacteol Fort: a randomized, double-blind, cross-over trial ' () 91 American Journal of Gastroenterology : 1579 -1585.
Higashikawa, F., Noda, M., Awaya, T., Danshiitsoodol, N., Matoba, Y., Kumagai, T. and Sugiyama, M., 2016. Antiobesity effect of Pediococcus pentosaceus LP28 on overweight subjects: a randomized, double-blind, placebo-controlled clinical trial. European Journal of Clinical Nutrition 70: 582-587.
'Antiobesity effect of Pediococcus pentosaceus LP28 on overweight subjects: a randomized, double-blind, placebo-controlled clinical trial ' () 70 European Journal of Clinical Nutrition : 582 -587.
Higgins, J.P.T. and Green, S., 2011. Cochrane handbook for systematic reviews of interventions. Version 5.1.0. The Cochrane Collaboration, 2011. Available at: http://training.cochrane.org/handbook.
Hill, C., Guarner, F., Reid, G., Gibson, G.R., Merenstein, D.J., Pot, B., Morelli, L., Canani, R.B., Flint, H.J., Salminen, S., Calder, P.C. and Sanders, M.E., 2014. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews Gastroenterology and Hepatology 11: 506-514.
'Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic ' () 11 Nature Reviews Gastroenterology and Hepatology : 506 -514.
Hirose, Y., Yamamoto, Y., Yoshikai, Y. and Murosaki, S., 2013. Oral intake of heat-killed Lactobacillus plantarum L-137 decreases the incidence of upper respiratory tract infection in healthy subjects with high levels of psychological stress. Journal of Nutritional Science 2: e39.
'Oral intake of heat-killed Lactobacillus plantarum L-137 decreases the incidence of upper respiratory tract infection in healthy subjects with high levels of psychological stress ' () 2 Journal of Nutritional Science : e39.
Inoue, Y., Kambara, T., Murata, N., Komori-Yamaguchi, J., Matsukura, S., Takahashi, Y., Ikezawa, Z. and Aihara, M., 2014. Effects of oral administration of Lactobacillus acidophilus L-92 on the symptoms and serum cytokines of atopic dermatitis in Japanese adults: a double-blind, randomized, clinical trial. International Archives of Allergy and Immunology 165: 247-254.
'Effects of oral administration of Lactobacillus acidophilus L-92 on the symptoms and serum cytokines of atopic dermatitis in Japanese adults: a double-blind, randomized, clinical trial ' () 165 International Archives of Allergy and Immunology : 247 -254.
Ioannidis, J.P., 2009. Adverse events in randomized trials: neglected, restricted, distorted, and silenced. Archives of Internal Medicine 169: 1737-1739.
'Adverse events in randomized trials: neglected, restricted, distorted, and silenced ' () 169 Archives of Internal Medicine : 1737 -1739.
Kaila, M., Isolauri, E., Saxelin, M., Arvilommi, H. and Vesikari, T., 1995. Viable versus inactivated Lactobacillus strain GG in acute rotavirus diarrhoea. Archives of Disease in Childhood 72: 51-53.
'Viable versus inactivated Lactobacillus strain GG in acute rotavirus diarrhoea ' () 72 Archives of Disease in Childhood : 51 -53.
Kataria, J., Li, N., Wynn, J.L. and Neu, J., 2009. Probiotic microbes: do they need to be alive to be beneficial? Nutrition Reviews 67: 546-550.
'Probiotic microbes: do they need to be alive to be beneficial? ' () 67 Nutrition Reviews : 546 -550.
Khanna, V., Alam, S., Malik, A. and Malik, A., 2005. Efficacy of tyndalized Lactobacillus acidophilus in acute diarrhea. Indian Journal of Pediatrics 72: 935-938.
'Efficacy of tyndalized Lactobacillus acidophilus in acute diarrhea ' () 72 Indian Journal of Pediatrics : 935 -938.
Kirjavainen, P.V., Salminen, S.J. and Isolauri, E., 2003. Probiotic bacteria in the management of atopic disease: underscoring the importance of viability. Journal of Pediatric Gastroenterology and Nutrition 36: 223-227.
'Probiotic bacteria in the management of atopic disease: underscoring the importance of viability ' () 36 Journal of Pediatric Gastroenterology and Nutrition : 223 -227.
Kumpu, M., Kekkonen, R.A., Korpela, R., Tynkkynen, S., Järvenpää, S., Kautiainen, H., Allen E.K., Hendley, J.O., Pitkäranta, A. and Winther, B., 2015. Effect of live and inactivated Lactobacillus rhamnosus GG on experimentally induced rhinovirus colds: randomised, double blind, placebo-controlled pilot trial. Beneficial Microbes 6: 631-639.
'Effect of live and inactivated Lactobacillus rhamnosus GG on experimentally induced rhinovirus colds: randomised, double blind, placebo-controlled pilot trial ' () 6 Beneficial Microbes : 631 -639.
Lau, S., Gerhold, K., Zimmermann, K., Ockeloen, C.W., Rossberg, S., Wagner, P., Sulser, C., Bunikowski, R., Witt, I., Wauer, J., Beschorner, J., Menke, G., Hamelmann, E. and Wahn, U., 2012. Oral application of bacterial lysate in infancy decreases the risk of atopic dermatitis in children with 1 atopic parent in a randomized, placebo-controlled trial. Journal of Allergy and Clinical Immunology 129: 1040-1047.
'Oral application of bacterial lysate in infancy decreases the risk of atopic dermatitis in children with 1 atopic parent in a randomized, placebo-controlled trial ' () 129 Journal of Allergy and Clinical Immunology : 1040 -1047.
Li, S., Huang, X.L., Sui, J.Z., Chen, S.Y., Xie, Y.T., Deng, Y., Wang, J., Xie, L., Li, T.J., He, Y., Peng, Q.L., Qin, X. and Zeng, Z.Y., 2014. Meta-analysis of randomized controlled trials on the efficacy of probiotics in Helicobacter pylori eradication therapy in children. European Journal of Pediatrics 173: 153-161.
'Meta-analysis of randomized controlled trials on the efficacy of probiotics in Helicobacter pylori eradication therapy in children ' () 173 European Journal of Pediatrics : 153 -161.
Liévin-Le Moal, V., 2016. A gastrointestinal anti-infectious biotherapeutic agent: the heat-treated Lactobacillus LB. Therapeutic Advances in Gastroenterology 9: 57-75.
'A gastrointestinal anti-infectious biotherapeutic agent: the heat-treated Lactobacillus LB ' () 9 Therapeutic Advances in Gastroenterology : 57 -75.
Liévin-Le Moal, V. and Servin, A.L., 2014. Anti-infective activities of lactobacillus strains in the human intestinal microbiota: from probiotics to gastrointestinal anti-infectious biotherapeutic agents. Clinical Microbiology Reviews 27: 167-199.
'Anti-infective activities of lactobacillus strains in the human intestinal microbiota: from probiotics to gastrointestinal anti-infectious biotherapeutic agents ' () 27 Clinical Microbiology Reviews : 167 -199.
Liévin-Le Moal, V., Sarrazin-Davila, L.E. and Servin, A.L., 2007. An experimental study and a randomized, double blind, placebo-controlled clinical trial to evaluate the antisecretory activity of Lactobacillus acidophilus strain LB against non-rotavirus diarrhea. Pediatrics 120: e795-e803.
'An experimental study and a randomized, double blind, placebo-controlled clinical trial to evaluate the antisecretory activity of Lactobacillus acidophilus strain LB against non-rotavirus diarrhea ' () 120 Pediatrics : e795 -e803.
Linares, D.M., Ross, P. and Stanton, C., 2016. Beneficial microbes: the pharmacy in the gut. Bioengineered 7: 11-20.
'Beneficial microbes: the pharmacy in the gut ' () 7 Bioengineered : 11 -20.
McFarland, L.V., 2014. Use of probiotics to correct dysbiosis of normal microbiota following disease or disruptive events: a systematic review. BMJ Open 4: e005047.
'Use of probiotics to correct dysbiosis of normal microbiota following disease or disruptive events: a systematic review ' () 4 BMJ Open : e005047.
McFarland, L.V., 2015a. From Yaks to Yogurt: the history, development and current use of probiotics. Clinical Infectious Diseases 60 Suppl. 2: S85-S90.
'From Yaks to Yogurt: the history, development and current use of probiotics ' () 2 Clinical Infectious Diseases : S85 -S90.
McFarland, L.V., 2015b. Application of meta-analysis to specific research fields: lessons learned. World Journal of Meta-analysis 3: 188-192.
'Application of meta-analysis to specific research fields: lessons learned ' () 3 World Journal of Meta-analysis : 188 -192.
McFarland, L.V., 2016. Importance of subgroup analysis in probiotic meta-analyses. Letter to the editor. British Journal of Nutrition 116: 375-376.
'Importance of subgroup analysis in probiotic meta-analyses ' () 116 British Journal of Nutrition : 375 -376.
McFarland, L.V., Huang, Y., Wang, L. and Malfertheiner, P., 2016. Systematic review and meta-analysis: multi-strain probiotics as adjunct therapy for Helicobacter pylori eradication and prevention of adverse events. United European Journal of Gastroenterology 4: 546-561.
'Systematic review and meta-analysis: multi-strain probiotics as adjunct therapy for Helicobacter pylori eradication and prevention of adverse events ' () 4 United European Journal of Gastroenterology : 546 -561.
McFarland, L.V., Malfertheiner, P., Huang, Y. and Wang, L., 2015. Meta-analysis of single strain probiotics for the eradication of Helicobacter pylori and prevention of adverse events. World Journal of Meta-analysis 3: 97-117.
'Meta-analysis of single strain probiotics for the eradication of Helicobacter pylori and prevention of adverse events ' () 3 World Journal of Meta-analysis : 97 -117.
Merenstein, D.J., Foster, J. and DâAmico, F., 2009. A randomized clinical trial measuring the influence of kefir on antibiotic-associated diarrhea. The measuring the influence of kefir (MILK) study. Archives of Pediatrics and Adolescent Medicine 163: 750-754.
'A randomized clinical trial measuring the influence of kefir on antibiotic-associated diarrhea ' () 163 Archives of Pediatrics and Adolescent Medicine : 750 -754.
Mitra, A. and Rabbani, G., 1990. A double-blind, controlled trial of Bioflorin (Streptococcus faecium SF68) in adults with acute diarrhea due to Vibrio cholerae and enterotoxigenic Escherichia coli. Gastroenterology 99: 1149-1152.
'A double-blind, controlled trial of Bioflorin (Streptococcus faecium SF68) in adults with acute diarrhea due to Vibrio cholerae and enterotoxigenic Escherichia coli ' () 99 Gastroenterology : 1149 -1152.
Miyazawa, K., Kawase, M., Jubota, A., Yoda, K., Harata, G., Hosoda, M. and He, F., 2015. Heat-killed Lactobacillus gasseri can enhance immunity in the elderly in a double-blind, placebo-controlled clinical study. Beneficial Microbes 6: 441-449.
'Heat-killed Lactobacillus gasseri can enhance immunity in the elderly in a double-blind, placebo-controlled clinical study ' () 6 Beneficial Microbes : 441 -449.
Moher, D., Hopewell, S., Schulz, K.F., Montori, V., Gøtzsche, P.C., Devereaux, P.J., Elbourne, D., Egger, M. and Altman, D.G., 2010. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomized trials. Journal of Clinical Epidemiology 63: e1-e37.
'CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomized trials ' () 63 Journal of Clinical Epidemiology : e1 -e37.
Morisset, M., Aubert-Jacquin, C., Soulaines, P., Moneret-Vautrin, D.A. and Dupont, C., 2011. A non-hydrolyzed, fermented milk formula reduces digestive and respiratory events in infants at high risk of allergy. European Journal of Clinical Nutrition 65: 175-183.
'A non-hydrolyzed, fermented milk formula reduces digestive and respiratory events in infants at high risk of allergy ' () 65 European Journal of Clinical Nutrition : 175 -183.
Moroi, M., Uchi, S., Nakamura, K., Sato, S., Shimizu, N., Fujii, M., Kumagai, T., Saito, M., Uchiyama, K., Watanabe, T., Yamaguchi, H., Yamamoto, T., Takeuchi, S. and Furue, M., 2011. Beneficial effect of a diet containing heat-killed Lactobacillus paracasei K71 on adult type atopic dermatitis. Journal of Dermatology 38: 131-139.
'Beneficial effect of a diet containing heat-killed Lactobacillus paracasei K71 on adult type atopic dermatitis ' () 38 Journal of Dermatology : 131 -139.
Murosaki, S., Yamamoto, Y., Yotsumoto, H., Kubo, H., Nomoto, S., Usuki, K., Katahira, Y., Shimada, T., Nishi, M., Hisadome, H., Yotsumoto, S. and Nomoto, K., 2006. Effects of intake syrup supplemented with Nigerooligosaccharides lactobacillus and heat killed Lactobacillus plantarum L137 on skin symptom and immune function in patients with atopic dermatitis. Japan Pharmacology and Therapeutics 34: 1087-1096.
'Effects of intake syrup supplemented with Nigerooligosaccharides lactobacillus and heat killed Lactobacillus plantarum L137 on skin symptom and immune function in patients with atopic dermatitis ' () 34 Japan Pharmacology and Therapeutics : 1087 -1096.
Okawa, T., Kita, M., Arai, T., Iida, K., Dokiya, T., Takegawa, Y., Hirokawa, Y., Yamazaki, K., and Hashimoto, S., 1989. Phase II randomized clinical trial of LC9018 concurrently used with radiation in the treatment of carcinoma of the uterine cervix. Its effect on tumor reduction and histology. Cancer 64: 1769-1776.
'Phase II randomized clinical trial of LC9018 concurrently used with radiation in the treatment of carcinoma of the uterine cervix ' () 64 Cancer : 1769 -1776.
Okawa, T., Niibe, H., Arai, T., Sekiba, K., Noda, K., Takeuchi, S., Hashimoto, S. and Ogawa, N., 1993. Effect of LC9018 combined with radiation therapy on carcinoma of the uterine cervix: a phase 3, multicenter, randomized, controlled study. Cancer 72: 1949-1954.
'Effect of LC9018 combined with radiation therapy on carcinoma of the uterine cervix: a phase 3, multicenter, randomized, controlled study ' () 72 Cancer : 1949 -1954.
Oláh, A., Belágyi, T., Issekutz, A., Gamal, M.E. and Bengmark, S., 2002. Randomized clinical trial of specific lactobacillus and fibre supplement to early enteral nutrition in patients with acute pancreatitis. British Journal of Surgery 89: 1103-1107.
'Randomized clinical trial of specific lactobacillus and fibre supplement to early enteral nutrition in patients with acute pancreatitis ' () 89 British Journal of Surgery : 1103 -1107.
Peng, G.C. and Hsu, C.H., 2005. The efficacy and safety of heat-killed Lactobacillus paracasei for treatment of perennial allergic rhinitis induced by house-dust mite. Pediatric Allergy and Immunology 16: 433-443.
'The efficacy and safety of heat-killed Lactobacillus paracasei for treatment of perennial allergic rhinitis induced by house-dust mite ' () 16 Pediatric Allergy and Immunology : 433 -443.
Peters, J.L., Sutton, A.J., Jones, D.R., Abrams, K.R. and Rushton, L., 2006. Comparison of two methods to detect publication bias in meta-analysis. Journal American Medical Association 295: 676-680.
'Comparison of two methods to detect publication bias in meta-analysis ' () 295 Journal American Medical Association : 676 -680.
Prospero, 2016. Available at: www.crd.york.ac.uk/PROSPERO.
Rayes, N., Hansen, S., Seehofer, D., Müller, A.R., Serke, S., Bengmark, S. and Neuhaus, P., 2002a. Early enteral supply of fiber and lactobacilli versus conventional nutrition: a controlled trial in patients with major abdominal surgery. Nutrition 18: 609-615.
'Early enteral supply of fiber and lactobacilli versus conventional nutrition: a controlled trial in patients with major abdominal surgery ' () 18 Nutrition : 609 -615.
Rayes, N., Seehofer, D., Hansen, S., Boucsein, K., Müller, A.R., Serke, S., Bengmark, S. and Neuhaus, P., 2002b. Early enteral supply of Lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant patients. Transplantation 74: 123-128.
'Early enteral supply of Lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant patients ' () 74 Transplantation : 123 -128.
Salazar-Lindo, E., Figueroa-Quintanilla, D., Caciano, M.I., Reto-Valiente, V., Chauviere, G. and Colin, P., 2007. Effectiveness and safety of Lactobacillus LB in the treatment of mild acute diarrhea in children. Journal of Pediatric Gastroenterology and Nutrition 44: 571-576.
'Effectiveness and safety of Lactobacillus LB in the treatment of mild acute diarrhea in children ' () 44 Journal of Pediatric Gastroenterology and Nutrition : 571 -576.
Salminen, M.K., Rautelin, H., Tynkkynen, S., Poussa, T., Saxelin, M., Valtonen, V. and Järvinen, A., 2006. Lactobacillus bacteremia, species identification, and antimicrobial susceptibility of 85 blood isolates. Clinical Infectious Diseases 42: e35-44.
'Lactobacillus bacteremia, species identification, and antimicrobial susceptibility of 85 blood isolates ' () 42 Clinical Infectious Diseases : e35 -44.
Sanders, M.E., 1998. Development of consumer probiotics for the US Market. British Journal of Nutrition 80: S213-S218.
'Development of consumer probiotics for the US Market ' () 80 British Journal of Nutrition : S213 -S218.
Sanders, M.E., Akkermans, L.M., Haller, D., Hammerman, C., Heimbach, J., Hörmannsperger, G., Huys, G., Levy, D.D., Lutgendorff, F., Mack, D., Phothirath, P., Solano-Aguilar, G. and Vaughan, E., 2010. Safety assessment of probiotics for human use. Gut Microbes 1: 164-185.
'Safety assessment of probiotics for human use ' () 1 Gut Microbes : 164 -185.
Sanders, M.E., Merenstein, D.J., Ouwehand, A.C., Reid, G., Salminen, S., Cabana, M.D., Paraskevakos, G. and Leyer, G., 2016. Probiotic use in at-risk populations. Journal of the American Pharmacists Association 56: 680-686.
'Probiotic use in at-risk populations ' () 56 Journal of the American Pharmacists Association : 680 -686.
Sharieff, W., Bhutta, Z., Schauer, C., Tomlinson, G. and Zlotkin, S., 2006. Micronutrients (including zinc) reduce diarrhoea in children: the Pakistan sprinkles diarrhoea study. Archives of Disease in Childhood 91: 573-579.
'Micronutrients (including zinc) reduce diarrhoea in children: the Pakistan sprinkles diarrhoea study ' () 91 Archives of Disease in Childhood : 573 -579.
Shinkai, S., Toba, M., Saito, T., Sato, I., Tsubouchi, M., Taira, K., Kakumoto, K., Inamatsu, T., Yoshida, H., Fujiwara, Y., Fukaya, T., Matsumoto, T., Tateda, K., Yamaguchi, K., Kohda, N. and Kohno, S., 2013. Immunoprotective effects of oral intake of heat-killed Lactobacillus pentosus strain b240 in elderly adults: a randomised, double-blind, placebo-controlled trial. British Journal of Nutrition 109: 1856-1865.
'Immunoprotective effects of oral intake of heat-killed Lactobacillus pentosus strain b240 in elderly adults: a randomised, double-blind, placebo-controlled trial ' () 109 British Journal of Nutrition : 1856 -1865.
Simakachorn, N., Pichaipat, V., Rithipornpaisarn, P., Kongkaew, C., Tongpradit, P. and Varavithya, W., 2000. Clinical evaluation of the addition of lyophilized, heat-killed Lactobacillus acidophilus LB to oral rehydration therapy in the treatment of acute diarrhea in children. Journal of Pediatric Gastroenterology and Nutrition 30: 68-72.
'Clinical evaluation of the addition of lyophilized, heat-killed Lactobacillus acidophilus LB to oral rehydration therapy in the treatment of acute diarrhea in children ' () 30 Journal of Pediatric Gastroenterology and Nutrition : 68 -72.
Singh, S. and Loke, Y.K., 2012. Drug safety assessment in clinical trials: methodological challenges and opportunities. Trials 13: 138.
'Drug safety assessment in clinical trials: methodological challenges and opportunities ' () 13 Trials : 138.
Sun, X., Briel, M., Walter, S. and Guyatt, G.H., 2010. Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analysis. British Medical Journal 340: 850-854.
'Is a subgroup effect believable? ' () 340 British Medical Journal : 850 -854.
Taverniti, V. and Guglielmetti, S., 2011. The immunomodulatory properties of probiotic microorganisms beyond their viability (ghost probiotics: proposal of paraprobiotic concept). Genes and Nutrition 6: 261-274.
'The immunomodulatory properties of probiotic microorganisms beyond their viability (ghost probiotics: proposal of paraprobiotic concept) ' () 6 Genes and Nutrition : 261 -274.
Vitko, H.A., Sekula, L.K. and Schreiber, M.A., 2017. Probiotics for trauma patients: should we be taking a precautionary approach? Journal of Trauma Nursing 24: 46-52.
'Probiotics for trauma patients: should we be taking a precautionary approach? ' () 24 Journal of Trauma Nursing : 46 -52.
Wang, Y.H, Yao, N., Wei, K.K., Jiang, L., Hanif, S., Wang, Z.X. and Pei, C.X., 2016. The efficacy and safety of probiotics for prevention of chemoradiotherapy-induced diarrhea in people with abdominal and pelvic cancer: a systematic review and meta-analysis. European Journal of Clinical Nutrition 70: 1246-1253.
'The efficacy and safety of probiotics for prevention of chemoradiotherapy-induced diarrhea in people with abdominal and pelvic cancer: a systematic review and meta-analysis ' () 70 European Journal of Clinical Nutrition : 1246 -1253.
Wenus, C., Goll, R., Loken, E.B., Biong, A.S., Halvorsen, D.S. and Florholmen, J., 2008. Prevention of antibiotic-associated diarrhoea by a fermented probiotic milk drink. European Journal of Clinical Nutrition 62: 299-301.
'Prevention of antibiotic-associated diarrhoea by a fermented probiotic milk drink ' () 62 European Journal of Clinical Nutrition : 299 -301.
Xiao, S.D., Zhang, D.Z., Lu, H., Jiang, S.H., Liu, H.Y., Wang, G.S., Xu, G.M., Zhang, Z.B., Lin, G.J. and Wang, G.L., 2003. Multicenter, randomized, controlled trial of heat-killed Lactobacillus acidophilus LB in patients with chronic diarrhea. Advances in Therapy 20: 253-260.
'Multicenter, randomized, controlled trial of heat-killed Lactobacillus acidophilus LB in patients with chronic diarrhea ' () 20 Advances in Therapy : 253 -260.
Yi, S.H., Jernigan, J.A. and McDonald, L.C., 2016. Prevalence of probiotic use among inpatients: a descriptive study of 145 U.S. hospitals. American Journal of Infection Control 44: 548-553.
'Prevalence of probiotic use among inpatients: a descriptive study of 145 U.S ' () 44 American Journal of Infection Control : 548 -553.
Zhu, R., Chen, K. and Zheng, Y.Y., 2014. Meta-analysis of the efficacy of probiotics in Helicobacter pylori eradication therapy. World Journal of Gastroenterology 20: 18013-18021.
'Meta-analysis of the efficacy of probiotics in Helicobacter pylori eradication therapy ' () 20 World Journal of Gastroenterology : 18013 -18021.
| å ¨é¨æé´ | è¿å»ä¸å¹´ | è¿å»30天 | |
|---|---|---|---|
| æè¦æµè§æ¬¡æ° | 1618 | 345 | 36 |
| å ¨ææµè§æ¬¡æ° | 43 | 11 | 0 |
| PDFä¸è½½æ¬¡æ° | 63 | 32 | 0 |
Our objective was to conduct a systematic review and meta-analysis for the use of modified (heat-killed or sonicated) probiotics for the efficacy and safety to prevent and treat various diseases. Recent clinical research has focused on living strains of probiotics, but use in high-risk patients and potential adverse reactions including bacteremia has focused interest on alternatives to the use of live probiotics. We searched MEDLINE/PubMed, Embase, Cochrane Central Register of Controlled Trials, CINAHL, Alt Health Watch, Web of Science, Scopus, PubMed, from inception to February 14, 2017 for randomised controlled trials involving modified probiotic strains. The primary outcome was efficacy to prevent or treat disease and the secondary outcome was incidence of adverse events. A total of 40 trials were included (n=3,913): 14 trials (15 arms with modified probiotics and 20 control arms) for the prevention of diseases and 26 trials (29 arms with modified probiotics and 32 control arms) for treatment of various diseases. Modified microbes were compared to either placebo (44%), or the same living probiotic strain (39%) or to only standard therapies (17%). Modified microbes were not significantly more or less effective than the living probiotic in 86% of the preventive trials and 69% of the treatment trials. Modified probiotic strains were significantly more effective in 15% of the treatment trials. Incidence rates of adverse events were similar for modified and living probiotics and other control groups, but many trials did not collect adequate safety data. Although several types of modified probiotics showed significant efficacy over living strains of probiotics, firm conclusions could not be reached due to the limited number of trials using the same type of modified microbe (strain, daily dose and duration) for a specific disease indication. Further research may illuminate other strains of modified probiotics that may have potential as clinical biotherapeutics.
| å ¨é¨æé´ | è¿å»ä¸å¹´ | è¿å»30天 | |
|---|---|---|---|
| æè¦æµè§æ¬¡æ° | 1618 | 345 | 36 |
| å ¨ææµè§æ¬¡æ° | 43 | 11 | 0 |
| PDFä¸è½½æ¬¡æ° | 63 | 32 | 0 |